Massive Bio was proud to sponsor the FLASCO (@FLASCO_ORG) 2026 Clinical Oncology Series: Malignant Hematology in Tampa alongside @AstraZeneca, Geron, @LillyOncMed, @pfizer Oncology, and @TakedaOncology. Representing Massive Bio on site were our Co-Founder, CTO & COO Çağatay M. Çulcuoğlu and our SVP, U.S. Provider Engagement and Partnerships, Toygun Onaran, joined by Dr. Henry Idrobo Quintero, Vice President of GELL, our partner organization advancing lymphoma and hematologic malignancy research across Latin America. Thank you to everyone who stopped by to connect and learn more about how Massive Bio helps expand access to clinical trials for patients with hematologic malignancies. @FLASCO_ORG @Grupo_GELL #ClinicalTrials #Hematology #Oncology